Pandey Saurabh, Rai Priyanka, Guha Subhasish Kamal, Maji Ardhendu, Ghosh Subir, Halder Prantiki, Gupta Manoj Kumar, Halder Soumen Nath, Modak Dolanchampa
Department of Tropical Medicine, School of Tropical Medicine, Kolkata, West Bengal, India.
J Glob Infect Dis. 2022 Jun 29;14(2):57-63. doi: 10.4103/jgid.jgid_279_21. eCollection 2022 Apr-Jun.
Co-infection with different agents such as bacterial, viral, and Rickettsia is being increasingly recognized due to greater availability and utilization of the diagnostic tests among malaria patients.
Consecutive admitted malarial cases were included and were subjected to test for general investigations, bacteria, typhoid, dengue, chikungunya, and rest for specific diagnosis. All patients were followed up till discharge or death and appropriate statistical tests were performed.
A total of 152 malaria patients were recruited and 27 (18.8%) had concurrent infections. It included 40.7% dengue only, 18.7% pneumonia, 11.1% urinary tract infection (UTI), 7.4% enteric fever, 3.7% leptospirosis, chikungunya, and tuberculous meningitis each, and 3.7% each of dengue with pneumonia and UTI. The organisms isolated were and The mean duration of fever was 6.33 ± 3.63 days with a range of 3-20 days. Blood culture grew in 2 cases and Dengue co-infections had significantly higher clinical and laboratory features of dengue and complications such as bleeding, jaundice, and cholecystitis, whereas rest concurrent infections had a significantly higher proportion of nausea and vomiting, convulsion, altered sensorium, productive cough, urinary symptoms, shock, acute kidney injury, anemia, and mean neutrophil count. There was significantly higher mortality among malaria-dengue concurrent infection group with 2 (15.4%) than malaria mono-infection group 3 (2.4%).
Co-infections with malaria are not uncommon, especially dengue fever and other bacterial infections. The dominant clinical picture is of the superimposed infection. Decision should be clinically guided adjunct with specific diagnostic tests, and timely treatment has favorable outcome.
由于疟疾患者中诊断检测的可及性和使用率提高,细菌、病毒和立克次体等不同病原体的合并感染越来越受到关注。
纳入连续收治的疟疾病例,并进行一般检查、细菌、伤寒、登革热、基孔肯雅热检测及其他特异性诊断检测。所有患者随访至出院或死亡,并进行适当的统计学检验。
共纳入152例疟疾病例,其中27例(18.8%)合并感染。仅登革热占40.7%,肺炎占18.7%,尿路感染(UTI)占11.1%,肠热症占7.4%,钩端螺旋体病、基孔肯雅热和结核性脑膜炎各占3.7%,登革热合并肺炎和UTI各占3.7%。分离出的病原体为……发热平均持续时间为6.33±3.63天,范围为3 - 20天。2例血培养阳性……登革热合并感染的登革热临床和实验室特征及出血、黄疸和胆囊炎等并发症显著更高,而其他合并感染恶心呕吐、惊厥、意识改变、咳痰、泌尿系统症状、休克、急性肾损伤、贫血和平均中性粒细胞计数的比例显著更高。疟疾 - 登革热合并感染组死亡率显著高于疟疾单一感染组,分别为2例(15.4%)和3例(2.4%)。
疟疾合并感染并不罕见,尤其是登革热和其他细菌感染。主要临床表现为叠加感染。临床决策应以特定诊断检测为辅助,及时治疗预后良好。